128 related articles for article (PubMed ID: 15263792)
21. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
[TBL] [Abstract][Full Text] [Related]
22. P53 codon 72 polymorphism in breast cancer.
Buyru N; Tigli H; Dalay N
Oncol Rep; 2003; 10(3):711-4. PubMed ID: 12684648
[TBL] [Abstract][Full Text] [Related]
23. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
Yapijakis C; Serefoglou Z; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E; Vairaktaris E
Anticancer Res; 2009 Jun; 29(6):2379-86. PubMed ID: 19528505
[TBL] [Abstract][Full Text] [Related]
24. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
25. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
Bonafé M; Ceccarelli C; Farabegoli F; Santini D; Taffurelli M; Barbi C; Marzi E; Trapassi C; Storci G; Olivieri F; Franceschi C
Clin Cancer Res; 2003 Oct; 9(13):4860-4. PubMed ID: 14581358
[TBL] [Abstract][Full Text] [Related]
26. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.
Bonafé M; Salvioli S; Barbi C; Trapassi C; Tocco F; Storci G; Invidia L; Vannini I; Rossi M; Marzi E; Mishto M; Capri M; Olivieri F; Antonicelli R; Memo M; Uberti D; Nacmias B; Sorbi S; Monti D; Franceschi C
Cell Death Differ; 2004 Sep; 11(9):962-73. PubMed ID: 15131588
[TBL] [Abstract][Full Text] [Related]
27. Validation of PCR-RFLP techniques for the evaluation of codon 72 of p53 and CYP1A1 gene's polymorphisms in relation with ovarian cancer in a Romanian population.
Matei MC; Negură L; Liliac L; Negură A; Azoicăi D
Rom J Morphol Embryol; 2012; 53(1):47-54. PubMed ID: 22395499
[TBL] [Abstract][Full Text] [Related]
28. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
[TBL] [Abstract][Full Text] [Related]
29. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
30. Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population.
Omori S; Yoshida S; Kennedy SH; Negoro K; Hamana S; Barlow DH; Maruo T
J Soc Gynecol Investig; 2004 May; 11(4):232-6. PubMed ID: 15120697
[TBL] [Abstract][Full Text] [Related]
31. E-cadherin gene 3'-UTR C/T polymorphism is associated with prostate cancer.
Wu HC; Lai MT; Wu CI; Chen HY; Wan L; Tsai FJ; Chen WC
Urol Int; 2005; 75(4):350-3. PubMed ID: 16327305
[TBL] [Abstract][Full Text] [Related]
32. [Potential effect of tumor necrosis factor-alpha and tumor necrosis factor receptor II gene polymorphisms on the pathogenesis of silicosis].
Li L; Yu C; Qi F; Li DH; Liu BC
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):323-6. PubMed ID: 15555301
[TBL] [Abstract][Full Text] [Related]
33. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
[TBL] [Abstract][Full Text] [Related]
34. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
Hu Y; McDermott MP; Ahrendt SA
Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms of estrogen receptor alpha in prostate cancer.
Tanaka Y; Sasaki M; Kaneuchi M; Shiina H; Igawa M; Dahiya R
Mol Carcinog; 2003 Aug; 37(4):202-8. PubMed ID: 12891629
[TBL] [Abstract][Full Text] [Related]
36. [Association between tumor necrosis factor alpha gene polymorphism and colorectal cancer].
Wu GY; Wang XM; Keese M; Hasenberg T; Sturm JW
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Nov; 11(6):569-71. PubMed ID: 19031138
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
[TBL] [Abstract][Full Text] [Related]
38. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
39. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
40. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
